$1.26 Billion is the total value of BRIDGER MANAGEMENT, LLC's 33 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 26.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDDY | Sell | GODADDY INCcl a | $79,468,000 | +9.4% | 1,056,900 | -4.5% | 6.29% | +3.9% |
| MDCO | Sell | MEDICINES CO | $79,427,000 | +35.6% | 2,841,761 | -7.2% | 6.29% | +28.8% |
| DRNA | DICERNA PHARMACEUTICALS INC | $69,935,000 | +37.0% | 4,773,718 | 0.0% | 5.54% | +30.1% | |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $69,669,000 | -9.1% | 1,752,690 | -20.6% | 5.51% | -13.7% |
| POST | Sell | POST HLDGS INC | $65,524,000 | +3.6% | 598,943 | -15.6% | 5.19% | -1.7% |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $59,478,000 | +21.7% | 171,451 | 0.0% | 4.71% | +15.6% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $58,168,000 | +21.1% | 622,450 | -5.5% | 4.60% | +15.0% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $56,581,000 | +30.6% | 4,181,892 | 0.0% | 4.48% | +24.0% | |
| MS | Sell | MORGAN STANLEY | $53,361,000 | -1.3% | 1,264,488 | -7.2% | 4.22% | -6.3% |
| LH | New | LABORATORY CORP AMER HLDGS | $50,647,000 | – | 331,069 | +100.0% | 4.01% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $49,765,000 | -22.7% | 2,036,199 | -18.0% | 3.94% | -26.6% |
| MGM | Sell | MGM RESORTS INTERNATIONAL | $45,388,000 | -5.8% | 1,768,829 | -11.0% | 3.59% | -10.6% |
| WMGI | WRIGHT MED GROUP N V | $44,792,000 | +15.5% | 1,424,239 | 0.0% | 3.54% | +9.7% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $41,613,000 | +11.6% | 1,238,489 | +9.2% | 3.29% | +6.0% |
| GDS | Sell | GDS HLDGS LTDsponsored ads | $39,463,000 | +23.0% | 1,105,720 | -20.4% | 3.12% | +16.8% |
| VSAT | Sell | VIASAT INC | $37,214,000 | +10.6% | 480,179 | -15.9% | 2.95% | +5.0% |
| VRSN | Sell | VERISIGN INC | $36,849,000 | -14.6% | 202,960 | -30.2% | 2.92% | -18.9% |
| LBRDA | LIBERTY BROADBAND CORP | $35,766,000 | +27.6% | 390,292 | 0.0% | 2.83% | +21.2% | |
| ERI | Sell | ELDORADO RESORTS INC | $34,854,000 | -13.5% | 746,498 | -32.9% | 2.76% | -17.9% |
| TGTX | Buy | TG THERAPEUTICS INC | $32,188,000 | +107.1% | 4,003,481 | +5.6% | 2.55% | +96.6% |
| SHAK | Buy | SHAKE SHACK INCcl a | $30,650,000 | +47.7% | 518,181 | +13.4% | 2.43% | +40.2% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $27,531,000 | – | 215,594 | +100.0% | 2.18% | – |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $26,819,000 | +3.2% | 1,529,032 | -12.8% | 2.12% | -2.0% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $23,520,000 | +1.7% | 1,500,000 | 0.0% | 1.86% | -3.4% | |
| CNC | Buy | CENTENE CORP DEL | $19,742,000 | +6.6% | 371,783 | +131.5% | 1.56% | +1.2% |
| STAA | STAAR SURGICAL CO | $17,577,000 | +7.1% | 514,105 | 0.0% | 1.39% | +1.7% | |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $15,427,000 | +17.8% | 397,090 | +27.5% | 1.22% | +11.9% |
| PVG | PRETIUM RES INC | $14,135,000 | +1.3% | 1,651,328 | 0.0% | 1.12% | -3.8% | |
| CZR | Sell | CAESARS ENTMT CORP | $11,966,000 | -60.4% | 1,377,004 | -69.1% | 0.95% | -62.4% |
| GDEN | Sell | GOLDEN ENTMT INC | $11,646,000 | -43.3% | 822,487 | -35.9% | 0.92% | -46.2% |
| NVRO | New | NEVRO CORP | $11,448,000 | – | 183,141 | +100.0% | 0.91% | – |
| ENPH | New | ENPHASE ENERGY INC | $6,689,000 | – | 724,723 | +100.0% | 0.53% | – |
| DXCM | Sell | DEXCOM INC | $6,110,000 | -9.7% | 51,302 | -9.1% | 0.48% | -14.2% |
| AMRX | Exit | AMNEAL PHARMACEUTICALS INC | $0 | – | -1,021,420 | -100.0% | -1.15% | – |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -536,128 | -100.0% | -1.27% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -79,816 | -100.0% | -1.57% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -200,049 | -100.0% | -1.62% | – |
| FDC | Exit | FIRST DATA CORP NEW | $0 | – | -2,658,994 | -100.0% | -3.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.